[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Lubiprostone Market 2021 by Company, Regions, Type and Application, Forecast to 2026

June 2021 | 106 pages | ID: GAA30C6DA65EN
GlobalInfoResearch

US$ 3,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The Lubiprostone market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Lubiprostone size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Lubiprostone market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation

Lubiprostone market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
  • 8 mcg Capsules
  • 24 mcg Capsules
Market segment by Application, can be divided into
  • CIC and OIC
  • IBS-C
Market segment by players, this report covers
  • Takeda Pharmaceuticals
Market segment by regions, regional analysis covers
  • North America (United States, Canada, and Mexico)
  • Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
  • South America (Brazil, Argentina, Rest of South America)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 MARKET OVERVIEW

1.1 Product Overview and Scope of Lubiprostone
1.2 Classification of Lubiprostone by Type
  1.2.1 Overview: Global Lubiprostone Market Size by Type: 2020 Versus 2021 Versus 2026
  1.2.2 Global Lubiprostone Revenue Market Share by Type in 2020
  1.2.3 8 mcg Capsules
  1.2.4 24 mcg Capsules
1.3 Global Lubiprostone Market by Application
  1.3.1 Overview: Global Lubiprostone Market Size by Application: 2020 Versus 2021 Versus 2026
  1.3.2 CIC and OIC
  1.3.3 IBS-C
1.4 Global Lubiprostone Market Size & Forecast
1.5 Global Lubiprostone Market Size and Forecast by Region
  1.5.1 Global Lubiprostone Market Size by Region: 2016 VS 2021 VS 2026
  1.5.2 Global Lubiprostone Market Size by Region, (2016-2021)
  1.5.3 North America Lubiprostone Market Size and Prospect (2016-2026)
  1.5.4 Europe Lubiprostone Market Size and Prospect (2016-2026)
  1.5.5 Asia-Pacific Lubiprostone Market Size and Prospect (2016-2026)
  1.5.6 South America Lubiprostone Market Size and Prospect (2016-2026)
  1.5.7 Middle East and Africa Lubiprostone Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
  1.6.1 Lubiprostone Market Drivers
  1.6.2 Lubiprostone Market Restraints
  1.6.3 Lubiprostone Trends Analysis

2 COMPANY PROFILES

2.1 Takeda Pharmaceuticals
  2.1.1 Takeda Pharmaceuticals Details
  2.1.2 Takeda Pharmaceuticals Major Business
  2.1.3 Takeda Pharmaceuticals Lubiprostone Product and Solutions
  2.1.4 Takeda Pharmaceuticals Lubiprostone Revenue, Gross Margin and Market Share (2019-2021)
  2.1.5 Takeda Pharmaceuticals Recent Developments and Future Plans

3 MARKET COMPETITION, BY PLAYERS

3.1 Global Lubiprostone Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
  3.2.1 Top 3 Lubiprostone Players Market Share
  3.2.2 Top 10 Lubiprostone Players Market Share
  3.2.3 Market Competition Trend
3.3 Lubiprostone Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans

4 MARKET SIZE SEGMENT BY TYPE

4.1 Global Lubiprostone Revenue and Market Share by Type (2016-2021)
4.2 Global Lubiprostone Market Forecast by Type (2021-2026)

5 MARKET SIZE SEGMENT BY APPLICATION

5.1 Global Lubiprostone Revenue Market Share by Application (2016-2021)
5.2 Lubiprostone Market Forecast by Application (2021-2026)

6 NORTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION

6.1 North America Lubiprostone Revenue by Type (2016-2026)
6.2 North America Lubiprostone Revenue by Application (2016-2026)
6.3 North America Lubiprostone Market Size by Country
  6.3.1 North America Lubiprostone Revenue by Country (2016-2026)
  6.3.2 United States Lubiprostone Market Size and Forecast (2016-2026)
  6.3.3 Canada Lubiprostone Market Size and Forecast (2016-2026)
  6.3.4 Mexico Lubiprostone Market Size and Forecast (2016-2026)

7 EUROPE BY COUNTRY, BY TYPE, AND BY APPLICATION

7.1 Europe Lubiprostone Revenue by Type (2016-2026)
7.2 Europe Lubiprostone Revenue by Application (2016-2026)
7.3 Europe Lubiprostone Market Size by Country
  7.3.1 Europe Lubiprostone Revenue by Country (2016-2026)
  7.3.2 Germany Lubiprostone Market Size and Forecast (2016-2026)
  7.3.3 France Lubiprostone Market Size and Forecast (2016-2026)
  7.3.4 United Kingdom Lubiprostone Market Size and Forecast (2016-2026)
  7.3.5 Russia Lubiprostone Market Size and Forecast (2016-2026)
  7.3.6 Italy Lubiprostone Market Size and Forecast (2016-2026)

8 ASIA-PACIFIC BY REGION, BY TYPE, AND BY APPLICATION

8.1 Asia-Pacific Lubiprostone Revenue by Type (2016-2026)
8.2 Asia-Pacific Lubiprostone Revenue by Application (2016-2026)
8.3 Asia-Pacific Lubiprostone Market Size by Region
  8.3.1 Asia-Pacific Lubiprostone Revenue by Region (2016-2026)
  8.3.2 China Lubiprostone Market Size and Forecast (2016-2026)
  8.3.3 Japan Lubiprostone Market Size and Forecast (2016-2026)
  8.3.4 South Korea Lubiprostone Market Size and Forecast (2016-2026)
  8.3.5 India Lubiprostone Market Size and Forecast (2016-2026)
  8.3.6 Southeast Asia Lubiprostone Market Size and Forecast (2016-2026)
  8.3.7 Australia Lubiprostone Market Size and Forecast (2016-2026)

9 SOUTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION

9.1 South America Lubiprostone Revenue by Type (2016-2026)
9.2 South America Lubiprostone Revenue by Application (2016-2026)
9.3 South America Lubiprostone Market Size by Country
  9.3.1 South America Lubiprostone Revenue by Country (2016-2026)
  9.3.2 Brazil Lubiprostone Market Size and Forecast (2016-2026)
  9.3.3 Argentina Lubiprostone Market Size and Forecast (2016-2026)

10 MIDDLE EAST & AFRICA BY COUNTRY, BY TYPE, AND BY APPLICATION

10.1 Middle East & Africa Lubiprostone Revenue by Type (2016-2026)
10.2 Middle East & Africa Lubiprostone Revenue by Application (2016-2026)
10.3 Middle East & Africa Lubiprostone Market Size by Country
  10.3.1 Middle East & Africa Lubiprostone Revenue by Country (2016-2026)
  10.3.2 Turkey Lubiprostone Market Size and Forecast (2016-2026)
  10.3.3 Saudi Arabia Lubiprostone Market Size and Forecast (2016-2026)
  10.3.4 UAE Lubiprostone Market Size and Forecast (2016-2026)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES

Table 1. Global Lubiprostone Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Lubiprostone Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Lubiprostone Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Lubiprostone Revenue (USD Million) by Region (2016-2021)
Table 5. Global Lubiprostone Revenue Market Share by Region (2021-2026)
Table 6. Takeda Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 7. Takeda Pharmaceuticals Major Business
Table 8. Takeda Pharmaceuticals Lubiprostone Product and Solutions
Table 9. Takeda Pharmaceuticals Lubiprostone Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Global Lubiprostone Revenue (USD Million) by Players (2019-2021)
Table 11. Global Lubiprostone Revenue Share by Players (2019-2021)
Table 12. Breakdown of Lubiprostone by Company Type (Tier 1, Tier 2 and Tier 3)
Table 13. Lubiprostone Players Head Office, Products and Services Provided
Table 14. Lubiprostone Mergers & Acquisitions in the Past Five Years
Table 15. Lubiprostone New Entrants and Expansion Plans
Table 16. Global Lubiprostone Revenue (USD Million) by Type (2016-2021)
Table 17. Global Lubiprostone Revenue Share by Type (2016-2021)
Table 18. Global Lubiprostone Revenue Forecast by Type (2021-2026)
Table 19. Global Lubiprostone Revenue by Application (2016-2021)
Table 20. Global Lubiprostone Revenue Forecast by Application (2021-2026)
Table 21. North America Lubiprostone Revenue by Type (2016-2021) & (USD Million)
Table 22. North America Lubiprostone Revenue by Type (2021-2026) & (USD Million)
Table 23. North America Lubiprostone Revenue by Application (2016-2021) & (USD Million)
Table 24. North America Lubiprostone Revenue by Application (2021-2026) & (USD Million)
Table 25. North America Lubiprostone Revenue by Country (2016-2021) & (USD Million)
Table 26. North America Lubiprostone Revenue by Country (2021-2026) & (USD Million)
Table 27. Europe Lubiprostone Revenue by Type (2016-2021) & (USD Million)
Table 28. Europe Lubiprostone Revenue by Type (2021-2026) & (USD Million)
Table 29. Europe Lubiprostone Revenue by Application (2016-2021) & (USD Million)
Table 30. Europe Lubiprostone Revenue by Application (2021-2026) & (USD Million)
Table 31. Europe Lubiprostone Revenue by Country (2016-2021) & (USD Million)
Table 32. Europe Lubiprostone Revenue by Country (2021-2026) & (USD Million)
Table 33. Asia-Pacific Lubiprostone Revenue by Type (2016-2021) & (USD Million)
Table 34. Asia-Pacific Lubiprostone Revenue by Type (2021-2026) & (USD Million)
Table 35. Asia-Pacific Lubiprostone Revenue by Application (2016-2021) & (USD Million)
Table 36. Asia-Pacific Lubiprostone Revenue by Application (2021-2026) & (USD Million)
Table 37. Asia-Pacific Lubiprostone Revenue by Region (2016-2021) & (USD Million)
Table 38. Asia-Pacific Lubiprostone Revenue by Region (2021-2026) & (USD Million)
Table 39. South America Lubiprostone Revenue by Type (2016-2021) & (USD Million)
Table 40. South America Lubiprostone Revenue by Type (2021-2026) & (USD Million)
Table 41. South America Lubiprostone Revenue by Application (2016-2021) & (USD Million)
Table 42. South America Lubiprostone Revenue by Application (2021-2026) & (USD Million)
Table 43. South America Lubiprostone Revenue by Country (2016-2021) & (USD Million)
Table 44. South America Lubiprostone Revenue by Country (2021-2026) & (USD Million)
Table 45. Middle East & Africa Lubiprostone Revenue by Type (2016-2021) & (USD Million)
Table 46. Middle East & Africa Lubiprostone Revenue by Type (2021-2026) & (USD Million)
Table 47. Middle East & Africa Lubiprostone Revenue by Application (2016-2021) & (USD Million)
Table 48. Middle East & Africa Lubiprostone Revenue by Application (2021-2026) & (USD Million)
Table 49. Middle East & Africa Lubiprostone Revenue by Country (2016-2021) & (USD Million)
Table 50. Middle East & Africa Lubiprostone Revenue by Country (2021-2026) & (USD Million)

LIST OF FIGURES

Figure 1. Lubiprostone Picture
Figure 2. Global Lubiprostone Revenue Market Share by Type in 2020
Figure 3. 8 mcg Capsules
Figure 4. 24 mcg Capsules
Figure 5. Lubiprostone Revenue Market Share by Application in 2020
Figure 6. CIC and OIC Picture
Figure 7. IBS-C Picture
Figure 8. Global Lubiprostone Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 9. Global Lubiprostone Revenue and Forecast (2016-2026) & (USD Million)
Figure 10. Global Lubiprostone Revenue Market Share by Region (2016-2026)
Figure 11. Global Lubiprostone Revenue Market Share by Region in 2020
Figure 12. North America Lubiprostone Revenue (USD Million) and Growth Rate (2016-2026)
Figure 13. Europe Lubiprostone Revenue (USD Million) and Growth Rate (2016-2026)
Figure 14. Asia-Pacific Lubiprostone Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. South America Lubiprostone Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Middle East and Africa Lubiprostone Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Lubiprostone Market Drivers
Figure 18. Lubiprostone Market Restraints
Figure 19. Lubiprostone Market Trends
Figure 20. Takeda Pharmaceuticals Recent Developments and Future Plans
Figure 21. Global Lubiprostone Revenue Share by Players in 2020
Figure 22. Lubiprostone Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 23. Global Top 3 Players Lubiprostone Revenue Market Share in 2020
Figure 24. Global Top 10 Players Lubiprostone Revenue Market Share in 2020
Figure 25. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 26. Global Lubiprostone Revenue Share by Type in 2020
Figure 27. Global Lubiprostone Market Share Forecast by Type (2021-2026)
Figure 28. Global Lubiprostone Revenue Share by Application in 2020
Figure 29. Global Lubiprostone Market Share Forecast by Application (2021-2026)
Figure 30. North America Lubiprostone Sales Market Share by Type (2016-2026)
Figure 31. North America Lubiprostone Sales Market Share by Application (2016-2026)
Figure 32. North America Lubiprostone Revenue Market Share by Country (2016-2026)
Figure 33. United States Lubiprostone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 34. Canada Lubiprostone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 35. Mexico Lubiprostone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 36. Europe Lubiprostone Sales Market Share by Type (2016-2026)
Figure 37. Europe Lubiprostone Sales Market Share by Application (2016-2026)
Figure 38. Europe Lubiprostone Revenue Market Share by Country (2016-2026)
Figure 39. Germany Lubiprostone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 40. France Lubiprostone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. United Kingdom Lubiprostone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Russia Lubiprostone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Italy Lubiprostone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Asia-Pacific Lubiprostone Sales Market Share by Type (2016-2026)
Figure 45. Asia-Pacific Lubiprostone Sales Market Share by Application (2016-2026)
Figure 46. Asia-Pacific Lubiprostone Revenue Market Share by Region (2016-2026)
Figure 47. China Lubiprostone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Japan Lubiprostone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. South Korea Lubiprostone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. India Lubiprostone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Southeast Asia Lubiprostone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Australia Lubiprostone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. South America Lubiprostone Sales Market Share by Type (2016-2026)
Figure 54. South America Lubiprostone Sales Market Share by Application (2016-2026)
Figure 55. South America Lubiprostone Revenue Market Share by Country (2016-2026)
Figure 56. Brazil Lubiprostone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Argentina Lubiprostone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Middle East and Africa Lubiprostone Sales Market Share by Type (2016-2026)
Figure 59. Middle East and Africa Lubiprostone Sales Market Share by Application (2016-2026)
Figure 60. Middle East and Africa Lubiprostone Revenue Market Share by Country (2016-2026)
Figure 61. Turkey Lubiprostone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Saudi Arabia Lubiprostone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. UAE Lubiprostone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Methodology
Figure 65. Research Process and Data Source


More Publications